Barrington Research Reaffirms Buy Rating for Varian

Barrington Research restated their buy rating on shares of Varian Medical Systems (NYSE:VAR) in a research note released on Thursday.

“We are maintaining our OUTPERFORM investment rating on VAR shares and are increasing our price target to $135 from our previous $132. We arrive at our price target by attaching a 17.5x multiple to our adjusted EBITDA estimate for FY/19. We assume $800 million in net cash 12 months from now.”,” the firm’s analyst commented.

https://www.fairfieldcurrent.com/news/2019/01/27/barrington-research-reaffirms-buy-rating-for-varian-medical-systems-var.html